Table 9.8a

Adjusted Graft Survival, Deceased Donor Liver Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2002 - 2003) (Tx 2002 - 2003) (Tx 2000 - 2003) (Tx 1998 - 2003)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 9,731 89.2% 0.3% 9,731 82.2% 0.4% 18,568 73.1% 0.4% 27,175 66.7% 0.4%
Primary Diagnosis Non-Cholestatic Cirrhosis 5,927 90.3% 0.4% 5,927 82.9% 0.5% 11,647 73.2% 0.5% 17,218 66.2% 0.5%
Cholestatic Liver Disease/Cirrhosis 963 91.1% 0.9% 963 86.2% 1.1% 1,870 77.9% 1.1% 2,896 72.8% 1.0%
Acute Hepatic Necrosis 735 82.4% 1.4% 735 74.1% 1.6% 1,553 67.0% 1.3% 2,289 63.3% 1.2%
Biliary Atresia 335 85.1% 2.4% 335 82.2% 2.6% 661 79.2% 2.0% 1,058 74.2% 1.8%
Metabolic Diseases 319 90.4% 1.7% 319 85.6% 2.0% 633 79.9% 1.8% 925 75.3% 1.7%
Malignant Neoplasms 620 90.1% 1.2% 620 82.0% 1.5% 825 65.9% 2.4% 1,010 54.3% 2.6%
Other 832 84.9% 1.3% 832 78.5% 1.5% 1,379 70.2% 1.4% 1,779 61.2% 1.6%


Source: OPTN/SRTR Data as of May 2, 2005.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure.Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on liver transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.